GLTSCR2

From Wikipedia, the free encyclopedia


Glioma tumor suppressor candidate region gene 2
Identifiers
Symbol(s) GLTSCR2; PICT-1; PICT1
External IDs OMIM: 605691 MGI: 2154441 HomoloGene: 44130
Orthologs
Human Mouse
Entrez 29997 68077
Ensembl ENSG00000105373 ENSMUSG00000041560
Uniprot Q9NZM5 n/a
Refseq NM_015710 (mRNA)
NP_056525 (protein)		 NM_133831 (mRNA)
NP_598592 (protein)
Location Chr 19: 52.94 - 52.95 Mb Chr 7: 15.1 - 15.1 Mb
Pubmed search [1] [2]

Glioma tumor suppressor candidate region gene 2, also known as GLTSCR2, is a human gene.[1]


[edit] References

  1. ^ Entrez Gene: GLTSCR2 glioma tumor suppressor candidate region gene 2.

[edit] Further reading

  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171–4. PMID 8125298. 
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149–56. PMID 9373149. 
  • Bruni R, Fineschi B, Ogle WO, Roizman B (1999). "A novel cellular protein, p60, interacting with both herpes simplex virus 1 regulatory proteins ICP22 and ICP0 is modified in a cell-type-specific manner and Is recruited to the nucleus after infection.". J. Virol. 73 (5): 3810–7. PMID 10196275. 
  • Smith JS, Tachibana I, Pohl U, et al. (2000). "A transcript map of the chromosome 19q-arm glioma tumor suppressor region.". Genomics 64 (1): 44–50. doi:10.1006/geno.1999.6101. PMID 10708517. 
  • Andersen JS, Lyon CE, Fox AH, et al. (2002). "Directed proteomic analysis of the human nucleolus.". Curr. Biol. 12 (1): 1–11. PMID 11790298. 
  • Scherl A, Couté Y, Déon C, et al. (2003). "Functional proteomic analysis of human nucleolus.". Mol. Biol. Cell 13 (11): 4100–9. doi:10.1091/mbc.E02-05-0271. PMID 12429849. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039. 
  • Okahara F, Ikawa H, Kanaho Y, Maehama T (2004). "Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.". J. Biol. Chem. 279 (44): 45300–3. doi:10.1074/jbc.C400377200. PMID 15355975. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Andersen JS, Lam YW, Leung AK, et al. (2005). "Nucleolar proteome dynamics.". Nature 433 (7021): 77–83. doi:10.1038/nature03207. PMID 15635413. 
  • Okahara F, Itoh K, Nakagawara A, et al. (2007). "Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.". Mol. Biol. Cell 17 (11): 4888–95. doi:10.1091/mbc.E06-04-0301. PMID 16971513. 
  • Yim JH, Kim YJ, Cho YE, et al. (2007). "GLTSCR2 sensitizes cells to hypoxic injury without involvement of mitochondrial apoptotic cascades.". Pathobiology 74 (5): 301–8. doi:10.1159/000105813. PMID 17890897. 
 This article on a gene on chromosome 19 is a stub. You can help Wikipedia by expanding it.